CardioDynamics Planning CHF Study Of BioZ.Com Hemodynamic Monitor
This article was originally published in The Gray Sheet
Executive Summary
A pivotal, multi-center study of CardioDynamics' BioZ.Com noninvasive hemodynamic monitor is anticipated to commence by year-end to evaluate its use in treating congestive heart failure.
You may also be interested in...
GEMS Rounds Out Cardiac Care Offerings Via Prucka Engineering Buy
Prucka Engineering's suite of cardiac catheterization and electrophysiology equipment will complement GE Marquette Medical Systems' offerings in diagnostic cardiology following an acquisition announced by both companies Aug. 24.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.